Evidence map›Paper›PMID 31286349›Full record

ArticleMolecular imaging and biology2020

Dose Reduction in Brain [

Marine Soret, Eve Piekarski, Nathanaëlle Yeni, Alain Giron, Jacques-Antoine Maisonobe, Maya Khalifé, Claire Zaslavsky, Marc Bertaux, Marie-Odile Habert, Aurélie Kas

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Impact of simulated reduced injected dose on the assessment of amyloid PET scans.European journal of nuclear medicine and molecular imaging · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Marine SoretMédecine Nucléaire, Hôpital Pitié-Salpêtrière, AP-HP, F-75013, Paris, France. marine.soret@aphp.fr.ORCID http://orcid.org/0000-0002-0097-7765
Eve PiekarskiMédecine Nucléaire, Hôpital Pitié-Salpêtrière, AP-HP, F-75013, Paris, France.
Nathanaëlle YeniMédecine Nucléaire, Hôpital Pitié-Salpêtrière, AP-HP, F-75013, Paris, France.
Alain GironLaboratoire d'Imagerie Biomédicale, LIB CNRS, INSERM, Sorbonne Université, CNRS, INSERM, F-75006, Paris, France.
Jacques-Antoine MaisonobeMédecine Nucléaire, Hôpital Pitié-Salpêtrière, AP-HP, F-75013, Paris, France.
Maya KhaliféInstitut du Cerveau et de la Moelle Epinière, CNRS UMR 7225, INSERM U1127, Université Paris 6 UPMC UMR S1127, F-75013, Paris, France.
Claire ZaslavskyLaboratoire d'Imagerie Biomédicale, LIB CNRS, INSERM, Sorbonne Université, CNRS, INSERM, F-75006, Paris, France.
Marc BertauxMédecine Nucléaire, Hôpital Pitié-Salpêtrière, AP-HP, F-75013, Paris, France.
Marie-Odile HabertMédecine Nucléaire, Hôpital Pitié-Salpêtrière, AP-HP, F-75013, Paris, France.
Aurélie KasMédecine Nucléaire, Hôpital Pitié-Salpêtrière, AP-HP, F-75013, Paris, France.
Centre National de la Recherche Scientifique · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIntegrated positron emission tomography (PET)/magnetic resonance imaging (MRI) offers promising tools for evaluating brain disorders, including the minimization of exposure to ionizing radiation. Considering the length of scanning time with PET/MRI systems and their high sensitivity, we assumed that the activity could be reduced by one half compared with recommended activity for brain 2-deoxy-2-[ PROCEDURES: We retrospectively simulated the reduction of injected activity (1 vs. 2 MBq/kg, [

resultsThe intra-operator agreement was high between the PET

conclusionsA reduction of the [

Indexed as

AgedAlzheimer DiseaseComputer SimulationFemaleFluorodeoxyglucose F18Frontotemporal DementiaHumansMagnetic Resonance ImagingMalePhantoms, ImagingPositron-Emission TomographyRadiation DosageRadiation ExposureRadiation ProtectionRadiopharmaceuticalsReproducibility of ResultsFluorodeoxyglucose F18Radiopharmaceuticals2-Deoxy-2-[18F]fluoro-D-glucoseDose reductionMagnetic resonanceNeurodegenerative diseasePositron emission tomographySUV

Identifiers

PMID31286349
OpenAlexW2959234405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.